← 返回列表 › SCI 期刊 › 医学 › Biomed Eng-Biomed Te

Biomedical Engineering-Biomedizinische Technik

Biomed Eng-Biomed Te

Print ISSN 0013-5585 Online ISSN 1862-278X
SCIE Q3 新锐4区 医学
影响因子 2026
1.3
↓ 0.5
5年均分
1.6
5-Year IF
H 指数
31
H-Index
年发文量
39
Articles / Year
出刊频率
Bimonthly
Pub. Frequency
创刊年份
1956
Founded Year
出版商
Walter De Gruyter Gmbh
Publisher
出版国家
Germany
Country
投稿参考 & 用户评分
🏆 期刊声誉
★★★★★
暂无
综合口碑评分,点击星星参与
⚡ 审稿速度
★★★★★
系统
暂无
约 0.5 个月
💰 版面费用
★★★★★
暂无
暂无APC数据,欢迎分享经验
中科院分区
2026新锐分区 新体系
大类4区
医学Medicine
小类4区
工程:生物医学
中科院2025年分区 传统体系
大类4区
医学Medicine
小类4区
工程:生物医学
WoS 期刊 JCR 分区 (2026 · JIF) 综合 SCIE Q3
学科 收录集 JIF 分区 JIF 排名 JIF 百分位
医学信息学 Medical Informatics SCIE Q4 53/54
1.9%
生物医学工程 Engineering, Biomedical SCIE Q4 113/130
13.1%
按 JCI 指标学科分区
学科 收录集 JCI 分区 JCI 排名 JCI 百分位
医学信息学 Medical Informatics SCIE Q4 32/33 JCI 0.32
6.1%
生物医学工程 Engineering, Biomedical SCIE Q4 84/103 JCI 0.32
19.4%
Scopus 指标
CiteScore
3.2
综合引用得分
SJR
0.334 Q3
SCImago Journal Rank
SNIP
0.566
Source Normalized Impact
JCI
0.32
Journal Citation Indicator
数据来源:Scopus (CiteScore · SJR · SNIP) · Clarivate (JCI)。指标年份:2026年6月最新版。
期刊简介

Biomedical Engineering-Biomedizinische Technik is a peer-reviewed scientific journal that serves as a vital platform for the dissemination of research at the intersection of engineering, physics, and clinical medicine. Published by De Gruyter, the journal covers a broad spectrum of topics within biomedical engineering, including but not limited to medical imaging, biosignal processing, biomaterials, biomechanics, rehabilitation engineering, and the development of novel diagnostic and therapeutic devices. The journal welcomes original research articles, comprehensive review papers, technical notes, and short communications that present significant experimental, theoretical, or computational advances. Its primary target audience comprises biomedical engineers, clinical researchers, physicists, and healthcare technology professionals seeking to bridge the gap between engineering innovation and medical application. While the journal offers an open access option for authors wishing to maximize the visibility and accessibility of their work, it also maintains a traditional subscription model. With a 2026 Impact Factor of 1.3000, the journal is currently positioned in the fourth quartile (Q4) within its subject area, reflecting a moderate level of citation impact relative to other publications in the field. Despite its Q4 ranking, the journal maintains relevance as a dedicated outlet for specialized research, particularly for studies that emphasize the integration of engineering principles into clinical practice. Its longstanding publication history and affiliation with the German Society for Biomedical Engineering contribute to its established presence in the community, making it a viable venue for researchers seeking to reach a focused, technically oriented readership.

历年影响因子 & 年发文量

上述信息均来源于网络,以官方发布为准,仅供参考。如有建议,欢迎反馈

生物行 © 2002–2026  All Rights Reserved.